Predictive Oncology
EAGAN, MN · Artificial Intelligence, Biotechnology, Blockchain · 20 employees
Predictive Oncology is on a mission to transform oncology drug discovery and drive the development of more effective cancer therapies. By leveraging machine learning, scientific expertise, and biologics, we work to increase the probability of success and advance drug compounds with greater precision and confidence.
Funding history
- Venture - Series Unknown — $173.3M — Oct 2025
- Venture - Series Unknown — $50.8M — Oct 2025
- Seed — $413K — Sep 2025
- Venture - Series Unknown — $2.2M — Aug 2024
- Venture - Series Unknown — $2.3M — Jun 2022
Recent signals
- Feb 09, 2026: Axe Compute Appoints Christopher Miglino as Chief Executive Officer
- Oct 22, 2025: Raised $173.3M in Venture - Series Unknown
- Oct 22, 2025: Raised $50.8M in Venture - Series Unknown
- Oct 14, 2025: Predictive Oncology Appoints Thomas McLaughlin as Chief Investment Officer and Sara Turken as General Counsel
- Sep 08, 2025: Raised $413K in Seed
- Feb 10, 2025: Predictive Oncology Partners with Tecan Group Ltd. for High-Throughput Drug Screening Expansion
- Dec 03, 2024: Launched Predictive Oncology Inc. evaluates strategic alternatives to enhance shareholder value as of December 3, 2024.
- Aug 02, 2024: Raised $2.2M in Venture - Series Unknown
See plans & pricing → Track Predictive Oncology’s funding, hiring, and signals — with verified contacts — on Fundz.